HUGO MANUEL LOPES DE SOUSA (AD12-737A-17C9)

Curriculum Vitae

HUGO MANUEL LOPES DE SOUSA

HUGO SOUSA started his academic career with a BScH in Microbiology (2003) followed by a Master Degree in Oncology (2005), a PhD in Biomedical Sciences (2011) and a Medical Degree (2014). Since January 2023 he is developing the Clinical Pathology internship/residence at the Centro Hospitalar Entre Douro e Vouga. Previously, HUGO SOUSA worked as a Clinical Scientist for the molecular diagnosis of viral infections at the Virology Service/Clinical Pathology Service of the Portuguese Oncology Institute of Porto (IPO Porto). Between March 2016 and December 2022, he was the coordinator of the HPV Test used in the Cervical Cancer Screening Program in the North Region of Portugal at IPO Porto performing over 100,000 tests/year. HUGO SOUSA is a Senior Researcher at the Molecular Oncology and Viral Pathology Group at IPO Porto Research Centre, where he was involved in the development of projects focused on viral infections and viral-associated cancers, namely: HPV and Cervical Cancer; EBV and Nasopharyngeal carcinoma; EBV and gastric Carcinoma; and herpesvirus infections in hematopoietic stem cell transplanted patients. HUGO SOUSA has been responsible for the supervision of more than 20 undergraduate students, 15 Master degree students and 2 PhD Students (completed), and published more than 80 manuscripts (https://www.ncbi.nlm.nih.gov/sites/myncbi/hugo.sousa.1/collections/62444132/public/), being 18 as last author (https://www.ncbi.nlm.nih.gov/sites/myncbi/hugo.sousa.1/collections/62444107/public/). HUGO SOUSA is Assistant Professor of Pathology at ISAVE – Institututo Superior de Saúde (since 2020); Invited Professor of Virology at the Superior School of Biotechnology (ESB-UCP) for many years (since 2012); and was Assistant Professor of Virology in the Faculty of Farmacy of University of Porto in 2022/23. Since 2011, HUGO SOUSA has been giving lectures for different academic and post-graduation courses. HUGO SOUSA has been involved in the organization of several meetings, including the “30th International Papillomavirus Conference & Clinical and Public Health Workshops” (17-21 September 2015 in Lisbon) and was responsible for the postgraduation course “1st Advanced Course in Clinical and Molecular Virology” (9-20 May 2016 in Porto). HUGO SOUSA was awarded by the European Society for Clinical Virology with the “2017 Abbot Diagnostic Virology Award” for his work in molecular virology and viral infections in immunocompromised hosts; and recently was awarded with the IDEX SCHOLARSHIP for the “European Master in Molecular Pathology” at Université Côte D’Azur. HUGO SOUSA is the Coordinator for the Working Group For Early Detection of the National Cancer Hub, a national structure supported by DGS and AICIB for consulting in the CANCER PLAN; and is a member of the European Society of Clinical Virology (ESCV)-network on NGS (ENNGS), aiming at the implementation of NGS in the clinical diagnostic laboratory, for pathogen detection and typing. The most frequent terms in the context of HUGO SOUSA scientific output are: cervical cancer, genetic polymorphisms, HPV, papillomavirus, EBV, Esptein-Barr Virus, Nasopharyngeal carcinoma, Gastric carcinoma, CMV, Cytomegalovirus, Immunocompromised hosts, hematopoietic stem cell transplant, virus, cancer.

Read full resume ↓

Identification

Personal identification

Full name: HUGO MANUEL LOPES DE SOUSA

Citation names

Sousa, Hugo

Author identifiers

Ciência ID: AD12-737A-17C9
ORCID iD: 0000-0001-5795-2131
Google Scholar ID: oALJ6iYAAAAJ&hl
Researcher Id: B-7714-2011
Scopus Author Id: 10139576800

Email addresses

hugomls@gmail.com (Professional)
hugo.sousa@ipoporto.min-saude.pt (Professional)
hugo.sousa@chedv.min-saude.pt (Professional)

Telephones

Telephone

225084000 Ext.: 5410 (Professional)

Addresses

Instituto Português de Oncologia do Porto FG, EPE. Rua Dr. António Bernardino de Almeida, 4200-072, Porto, Porto, Portugal (Professional)
Centro Hospitalar Entre Douro e Vouga, R. Dr. Cândido Pinho 5, 4520-211, Santa Maria da Feira, Santa Maria da Feira, Portugal (Professional)

Websites

http://hugomls.wix.com/home (Professional)

Knowledge fields

Medical and Health Sciences
Medical and Health Sciences - Basic Medicine - Pathology
Medical and Health Sciences - Health Sciences - Infectious Diseases
Natural sciences - Biological Sciences - Microbiology
Medical and Health Sciences - Basic Medicine - Pathology

Languages

Language	Speaking	Reading	Writing	Listening
English	Advanced (C1)	Advanced (C1)	Advanced (C1)	Advanced (C1)
French	Beginner (A1)	Intermediate (B1)	Beginner (A1)	Beginner (A1)
Spanish; Castilian	Beginner (A1)	Beginner (A1)	Beginner (A1)	Beginner (A1)

Education

	Degree	Classification
2023/09 - 2025/07 Ongoing	European Masters in Molecular Pathology (Mestrado) Université Côte d'Azur Faculté de Médecine, France
2019/11/05 - 2019/11/07 Concluded	5th Post-Graduate Course in Oncology for General Practitioners and Young Oncologists (Pós-Graduação) Centro Hospitalar Universitário do Porto EPE, Portugal
2019/10/03 Concluded	How to write great papers and get published (Outros) Elsevier Ltd, United Kingdom
2019/01/28 - 2019/02/08 Concluded	Laboratory Animal Science (Pós-Graduação) Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal	Aprovado
2017/10/14 - 2017/10/15 Concluded	Tuberculose (Outros) Unidade Local de Saúde do Nordeste EPE, Portugal
2017/05/19 - 2017/05/19 Concluded	3º curso de Gastrenterologia Oncológica (Outros) Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2017/04/18 - 2017/04/18 Concluded	Medicina da Dor (Outros) Ordem dos Médicos - Secção regional do Norte, Portugal
2017/04/17 - 2017/04/17 Concluded	Antibioterapia (Outros) Ordem dos Médicos - Secção regional do Norte, Portugal
2016/05/09 - 2016/05/20 Concluded	1st Advanced Course in Clinical and Molecular Virology (Curso de Especialização Tecnológica) Major in Virologia Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2015/07/14 - 2015/07/14 Concluded	Cost-Effectiveness in Oncology (Outros) Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2007/09 - 2014/09 Concluded	Medicina (Mestrado integrado) Major in Sem especialização Universidade do Porto Faculdade de Medicina, Portugal "Cytomegalovirus infection in bone marrow trasplanted patients from Portugal: a 5-year retrospestive review" (THESIS/DISSERTATION)	13,48 valores
2014/04 - 2014/04 Concluded	Educational Program on Transplant Infectious Diseases (Outros) European Society of Clinical Microbiology and Infectious Diseases, Switzerland
2013/06 - 2013/06 Concluded	Formação em Investigação Clínica e criação de Unidade de Investigação (Outros) Centro de Investigação em Decisão e Evidência em Saude, Portugal
2013 - 2013 Concluded	Statistical Analysis – Logistic Regression (Outros) Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal Centro de Investigação em Decisão e Evidência em Saude, Portugal
2013 - 2013 Concluded	Statistical Analysis – Survival Analysis (Outros) Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2006 - 2011/09/16 Concluded	Ciências Biomédicas (Doutoramento) Major in Sem especialidade Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal "Oncovirogenómics - genetic susceptibility to viral associated neoplasias" (THESIS/DISSERTATION)
2003/07 - 2005/12 Concluded	Oncologia (Mestrado) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal "ROLE OF EBNA2 IN EBV ASSOCIATED C-MYC ACTIVATION" (THESIS/DISSERTATION)	Muito Bom por Unanimidade
2004 - 2004 Concluded	Microarrays: Principles and Applications in Medicine (Outros) Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal Centro de Investigação em Decisão e Evidência em Saude, Portugal
1999 - 2003 Concluded	Microbiologia (Licenciatura) Universidade Católica Portuguesa Escola Superior de Biotecnologia, Portugal "n/a" (THESIS/DISSERTATION)	14 valores

Affiliation

Science

	Category Host institution	Employer
2005/06/06 - Current	Researcher (Research)	Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal

2018/11 - 2020/03	Contracted Researcher (Research)	Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal

2004/09 - 2005/05	Research Trainee (Research)	Ludwig Institute for Cancer Research , United Kingdom

2002/11 - 2004/08	Research Trainee (Research)	Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal

Teaching in Higher Education

	Category Host institution	Employer
2020/09 - Current	Adjunct Teacher (Polytechnic Teacher)	Instituto Superior de Saúde, Portugal
	Instituto Superior de Saúde, Portugal
2011/02/21 - Current	Visiting Professor (University Teacher)	Universidade Católica Portuguesa Escola Superior de Biotecnologia, Portugal

Other Careers

	Category Host institution	Employer
2023/01/01 - Current	Interno (Médica)	Centro Hospitalar de Entre o Douro e Vouga EPE, Portugal

2009/09 - Current	Técnico Superior (Técnico Superior)	Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Positions / Appointments

	Category Host institution	Employer
2012/07/01 - 2014/07/31	Group Leader	Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
	Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal

Others

	Category Host institution	Employer
2018/02 - Current	Médico Clinica Geral	Hospital Particular de Barcelos, Portugal

2018/01 - Current	Médico Clinica Geral	Hospital Santa Maria Maior, Portugal

2017/01/01 - 2017/12/31	Médico Interno Ano comum	Unidade Local de Saúde do Nordeste EPE, Portugal

2007 - 2009	Formador	Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Projects

Grant

	Designation	Funders
2020/08 - Current	CRISPR technology against the COVID-19 pandemic. The DETECTR of SARS-CoV-2 COVID19-2 - 480 Researcher International Iberian Nanotechnology Laboratory, Portugal	Fundação para a Ciência e a Tecnologia Ongoing
2020/05 - Current	Develop fast, highly accurate, low-cost PCR-based protocol to test SARS-CoV-2 COVID19 - 208_596865986 Researcher Laboratório Associado ICVS 3B's, Portugal	Fundação para a Ciência e a Tecnologia
2020/05 - Current	Developing a portable SERS chip for point-of-care analysis of virus-specific nucleic acid COVID19 - 172_596849991 Researcher International Iberian Nanotechnology Laboratory, Portugal	Fundação para a Ciência e a Tecnologia
2020/05 - Current	LAMP-Light in the diagnosis of COVID-19 COVID19 - 165_596847607 Researcher International Iberian Nanotechnology Laboratory, Portugal	Fundação para a Ciência e a Tecnologia Ongoing
2020 - 2021	iMalTrack: Imported malaria-tracking molecular markers of antimalarial drug resistance iMalTrack Researcher Laboratório Associado ICVS 3B's, Portugal	Centro Clínico Académico – Braga (2CA-Braga) Ongoing
2008/01/01 - 2009/09/30	ONCOVIROGENÓMICA: SUSCEPTIBILIDADE GENÉTICA NO DESENVOLVIMENTO DE NEOPLASIAS ASSOCIADAS A VÍRUS SFRH/BD/40718/2007	Fundação para a Ciência e a Tecnologia Concluded

Contract

	Designation	Funders
2022/01/01 - Current	Evaluation of the Immunologic Response to COVID-19 Vaccination in Oncological Patients OnCOVac.PT ONCOVAC.PT Researcher Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal	Fundação AstraZeneca Ongoing
2022/01/01 - Current	DC Matters - Combination of dendritic cell vaccine with immune checkpoint inhibitors NORTE-01-0247-FEDER-047212 Researcher	Ongoing
2018 - 2020	IMPAct-L: Innovative Microfluidic Platform for Analysis of myeloid Leukemia blasts POCI-01-0145-FEDER- 030782 Researcher International Iberian Nanotechnology Laboratory, Portugal	Fundação para a Ciência e a Tecnologia Ongoing
2018 - 2020	New avenues for the development of personalized medical interventions for neurological, oncologic and surgical diseases disorders Norte-01-0145-FEDER-000013 Researcher Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde, Portugal
2019/01/01 - 2019/12/31	Centro de Investigação do Instituto Português de Oncologia do Porto UID/DTP/00776/2019 Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal	Fundação para a Ciência e a Tecnologia Concluded
2012 - 2016	Polimorfismos em genes da via PGE2 (COX-2/HPGD/ABCC4/SLCO2A1) e carcinogénese Colo-Rectal 38/2012 Researcher Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal	Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação Concluded
2011/01/01 - 2013/12/31	Projecto Estratégico - UI 776 - 2011-2012 PEst-OE/SAU/UI0776/2011 Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal	Fundação para a Ciência e a Tecnologia Concluded
2007/07/01 - 2010/12/31	Perfil Farmacogenómico do Turnover Ósseo em Doentes com Cancro da Próstata Metastático: Factor Predictivo para o Tratamento com Bifosfonatos? PTDC/SAU-FCF/71552/2006 Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal Associação para a Investigação e Desenvolvimento da Faculdade de Medicina, Portugal	Fundação para a Ciência e a Tecnologia Concluded
2007/07 - 2010/12	Bone Turnover Associated-Pharmacogenomic Profile of Patients with Metastatic and Non-Metastatic Prostate Cancer: Predictive Factors for the Benefits of Bisphosphonate Treatment? 71552 Provided by PTCRIS: 71552 PTDC/SAU-FCF/71552/2006 Researcher Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal Associação para a Investigação e Desenvolvimento da Faculdade de Medicina, Portugal Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal	Fundação para a Ciência e a Tecnologia Concluded
2007 - 2010	Papel do Vírus de Epstein-Barr (EBV) e suas variantes genéticas na etiologia, valor de prognóstico e factor predictivo de resposta a terapia de pacientes com carcinoma gástrico MinSaude Researcher Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal	Ministério da Saúde Concluded
2006 - 2010	Potencial oncogénico das variantes L83V da proteína E6 do HPV-16 na inactivação das variantes R72P da p53 35-76491-S Principal investigator Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal	Fundação Calouste Gulbenkian Concluded
2007 - 2009	Caracterização Farmacogenómica da COX no cancro colorectal SPG2007 Researcher Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal	Sociedade Portuguesa de Gastrenterologia Concluded

Outputs

Publications

Book chapter	Sousa, Hugo. "EPSTEIN-BARR VIRUS ASSOCIATED GASTRIC CANCER: OLD ENTITY WITH NEW RELEVANCE". In Epstein-Barr Virus. IntechOpen, 2021. In press Sousa, Hugo; Medeiros, Rui; Longatto, Adhemar. "DIAGNÓSTICO PRECOCE E PREVENÇÃO DO CANCRO DO COLO DO ÚTERO PARA DIMINUIÇÃO DO CUSTO TOTAL DO TRATAMENTO". In Auditoria Prática na Oncologia – Associação brasileira de Enfermeiros Auditores. Fortaleza, Brazil, 2019. Published
Conference abstract	Pereira, Ana; Queirós, Sara; Galaghar, Ana; Sousa, Hugo; Marcos-Pinto, Ricardo; Pimentel-Nunes, Pedro; Brandão, Catarina; et al. Corresponding author: Pereira, Ana. "289 Genetic Variability in SLCO2A1 and ABCC4 Genes Encoding for Prostaglandin E2 Transporters Modulate the Susceptibility for Colorectal Adenomas Recurrence After Polypectomy: An Opportunity for Individualized Surveillance?". Paper presented in DDW 2015, 2015. Published • 10.1016/s0016-5085(15)30218-3 Pereira, Ana; Ribeiro, Joana; Queirós, Sara; Esteves, Marlene E.; Lima, Luís; Sousa, Hugo; Marcos-Pinto, Ricardo; et al. Corresponding author: Pereira, Ana. "Su1939 Influence of Genetic Polymorphisms in Prostaglandin E2 (PGE2) Pathway on mRNA Expression of COX-2, Hpgd, Abcc4 and Slco2a1 Genes in Colorectal Tumors". Paper presented in DDW 2015, 2015. Published • 10.1016/s0016-5085(15)31868-0 Lima, Aurea; Azevedo, Rita; Sousa, Hugo; Bernardes, Miguel; Medeiros, Rui; Seabra, Vítor. "SLC19A1, SLCO1B1 and ABCG2 polymorphisms are associated with Methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients". Paper presented in European League Against Rheumatism Congress 2014, Paris, 2014. Published Lima, Aurea; Bernardes, Miguel; Azevedo, Rita; Sousa, Hugo; Seabra, Vítor; Medeiros, Rui. "SLC22A11 T allele (rs11231809) as a predictor of Methotrexate non-response in Portuguese rheumatoid arthritis patients". Paper presented in XVII Congresso Português de Reumatologia, Algarve, 2014. Published Gil da Costa, R. M.; Pinto, D.; Sousa, H.; Matos, Eduarda; Rema, A.; Lopes, Célia C.; Medeiros, R.; Pires, M. A.; Gartner, F.. "The role of KIT in canine mast cell tumours: a biopathological study". Paper presented in 25th Meeting of the European Society of Veterinary Pathology, Munique, 2007. Published
Conference paper	Sousa, Hugo; Sousa, Ana Saraiva; Silva, Jani; Medeiros, Rui; Alves, André; Nogueira, Augusto; Alves, Maria José; Rodrigues, Andreia; Sá, Sílvia. "High prevalence of high-risk HPV infection in University students from the Northeast region of Portugal using self-sampling". 2019. Pereira, Carina; Sousa, Hugo; Pinto-Correia, A.L.; Teixeira, Ana Luísa; Fragoso, Maria; Moreira-Dias, Luís; Medeiros, Rui; Dinis-Ribeiro, Mário. "Gastric adenocarcinoma development in patients with atrophy and intestinal metaplasia: the role of COX-2 polymorphisms in a Northern Portuguese population". Paper presented in 18th United European Gastroenterology Week, 2010. Published • 10.1055/s-0038-1637251
Conference poster	Salta, S; Maia-Moço, L; Estevão-Pereira, Helena; José Pedro Sequeira; Vieira, R; BARTOSCH, CARLA; Petronilho, S; et al. "DNA methylation markers as potential tool for colposcopy referral in hr-HPV positive women enrolled in cervical cancer screening program". Paper presented in II ASPIC-ASEICA International Meeting ¿ Current Trends in Precision Medicine in Cancer, 2021. Torgal, Ana; Fonseca e Silva, Daniela; Marinho-Dias, Joana; Sousa, Hugo. "ESTUDO RETROSPECTIVO DA PESQUISA DE SARS-COV-2 EM DOENTES ONCOLÓGICOS E PROFISSIONAIS DE SAÚDE NUM HOSPITAL DO NORTE DE PORTUGAL". Paper presented in VII Jornadas do Médico Interno de Patologia Clínica, 5-6th November 2020., 2020. Fonseca e Silva, Daniela; Torgal, Ana; Braga, Sara; Sousa, Hugo. "SEROLOGICAL PREVALENCE OF SARS-COV2 IN HEALTH PROFESSIONALS, WITH PREVIOUSLY CONFIRMED INFECION, AT AN ONCOLOGY HOSPITAL IN THE NORTH OF PORTUGAL". Paper presented in ESCMID Conference on Coronavirus Disease (ECCVID), 2020. Sousa, Hugo. "CORRELATION BETWEEN HUMAN PAPILLOMAVIRUS GENOTYPES AND CITOLOGY IN THE NORTH REGION OF PORTUGAL: DATA FROM REGIONAL CERVICAL CANCER SCREENING". Paper presented in IPVC 2020, 2020. Timóteo, Mafalda; Sousa, Hugo. "MDM2 EXPRESSION IN EPSTEIN-BARR VIRUS-ASSOCIATED GASTRIC CANCERS". Paper presented in ECCMID 2020, 2020. Sousa, Hugo; Sampaio-Marques, B; Fernandes , Angela; Castro, Isabel; Sanz-Perez, Juan; LUDOVICO, PAULA. "CLINICAL IMPLICATIONS OF THE AUTOPHAGY CORE GENE VARIATIONS IN ACUTE MYELOID LEUKEMIA". Paper presented in ISCAM 2019, 2019. Silva, Helena; Castro, Isabel; Sousa, Rafael; Sousa, Hugo; Sampaio-Marques, B; LUDOVICO, PAULA. "INTEGRATION OF LIPID METABOLISM WITH KREBS CYCLE IN ACUTE MYELOID LEUKEMIA§". Paper presented in ISCAM, 2019. Cruz, Sara; Campos, Carla; Timóteo, Mafalda; Tavares, Ana; Nascimento, São José; Medeiros, Rui; Sousa, Hugo. "SYSTEMATIC REVIEW OF HEPATITIS E VIRUS PREVALENCE IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS". Paper presented in 22nd European Society for Clinical Virology's Annual Meeting, 2019. Timóteo, Mafalda; Ribeiro, Joana; Malta, Mariana; Medeiros, Rui; Sousa, Hugo; Malta, Mariana D.; MEDEIROS, RUI. "MDM2 REGULATION OF P53 IN EPSTEIN-BARR VIRUS ASSOCIATED GASTRIC CANCER (PRELIMINAR STUDY)". Paper presented in 22nd European Society for Clinical Virology's Annual Meeting, 2019. Sousa, Hugo. "HUMAN PAPILLOMAVIRUS GENOTYPE DISTRIBUTION IN THE NORTH REGION OF PORTUGAL: DATA FROM REGIONAL CERVICAL CANCER SCREENING". Paper presented in IPVC 2018, 2018. Ribeiro, Joana; Farinha, Mónica; Sousa, Hugo. "GASTRIC CARCINOMA WITH LYMPHOID STROMA: ANALYSIS OF MICROSATELLITE INSTABILITY AND EPSTEIN-BARR VIRUS STATUS". Paper presented in 13º Congresso Nacional Cancro Digestivo, 2017. Ribeiro, Joana; Malta, Mariana; Sousa, Hugo. "P53 EXPRESSION IN EPSTEIN-BARR VIRUS ASSOCIATED GASTRIC CANCER AND NASOPHARYNGEAL CARCINOMA". Paper presented in Microbiology Society Annual Conference 2017, 2017. Ribeiro, Joana; Malta, Mariana D.; Sousa, Hugo. "p53 expression in Epstein-Barr associated Gastric Cancer and Nasopharyngeal Carcinoma". Paper presented in Microbiology Society Annual Conference 2017, 2017. Ribeiro, Joana; Medeiros, Rui; Sousa, Hugo. "MONITORING OF CYTOMEGALOVIRUS-SPECIFIC IMMUNITY USING THE QUANTIFERON-CMV ASSAY IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: PRELIMINARY RESULTS". Paper presented in ESCV 2016, 2016. Malta, Mariana; Ribeiro, Joana; Sousa, Hugo. "p53 EXPRESSION IN EPSTEIN-BARR VIRUS ASSOCIATED GASTRIC CANCER AND NASOPHARYNGEAL CARCINOMA". Paper presented in EBV 2016 International Symposium, 2016. Ribeiro, Joana; Campos, Ana Bela; Sousa, Hugo. "CHARACTERIZATION OF HUMAN CYTOMEGALOVIRUS ANTIVIRAL-RESISTANT STRAINS IN ALLOGENEIC STEM CELL TRANSPLANTED PATIENTS FROM PORTUGAL". Paper presented in ECCMID 2016, 2016. Santos, Carlos; Sousa, Hugo; da Costa, Rui M. Gil. "ROLE OF CD8+ T CELLS IN HPV-INDUCED SKIN CANCER – DATA FROM A K14-HPV16 TRANSGENIC MOUSE MODEL". Paper presented in IPVC 2015, 2015. Malta, Mariana; Ribeiro, Joana; Monteiro, Paula; Loureiro, Joana; Medeiros, Rui; Sousa, Hugo. "LET-7C IS A CANDIDATE BIOMARKER FOR HPV-ASSOCIATED CERVICAL INTRAEPITHELIAL LESIONS". Paper presented in IPVC 2015, 2015. Ribeiro, Joana; Sousa, Hugo. "HPV DETECTION IN TONSILLAR SQUAMOUS CELL TYPE CARCINOMAS IN PORTUGAL - A TALE FROM OPORTO AND COIMBRA CENTERS". Paper presented in IPVC 2015, 2015. Ribeiro, Joana; Sousa, Hugo. "EPSTEIN-BARR VIRUS ASSOCIATED GASTRIC CARCINOMAS IN PORTUGA". Paper presented in ECCMID 2015, 2015. Pereira, Carina; Sousa, Hugo. "GENETIC VARIABILITY IN SLCO2A1 AND ABCC4 GENES ENCODING FOR PROSTAGLANDIN E2 TRANSPORTERS MODULATE THE SUSCEPTIBILITY FOR COLORECTAL ADENOMAS RECURRENCE AFTER POLYPECTOMY: AN OPPORTUNITY FOR INDIVIDUALIZED SURVEILLANCE?". Paper presented in Digestive Disease Week 2015, 2015. Pereira, Carina; Sousa, Hugo. "INFLUENCE OF GENETIC POLYMORPHISMS IN PROSTAGLANDIN E2 (PGE2) PATHWAY ON MRNA EXPRESSION OFCOX-2, HPGD, ABCC4 AND SLCO2A1 GENES IN COLORECTAL TUMORS". Paper presented in Digestive Disease Week 2015, 2015. Marinho-Dias, Joana; Sousa, Hugo. "EPSTEIN-BARR VIRUS VIRAL LOAD AND POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS". Paper presented in ECCMID 2015, 2015. Neves, Marco; Sousa, Hugo. "EPSTEIN-BARR VIRUS STRAINS AND LMP1 VARIANTS IN PORTUGAL". Paper presented in ECCMID 2015, 2015. Mesquita, Letícia; Sousa, Hugo. "EPSTEIN-BARR VIRUS INFECTION IN ALLOGENEIC HEMATOPOIETIC STEM CEL TRANSPLANT PATIENTS". Paper presented in 13º Congresso Nacional de Oncologia, 2014. Sousa, Hugo; Nunes, Marta; Campos Jr, António. "A. CYTOMEGALOVIRUS (CMV) VIRAL LOAS IN BRONCHOALVELOLAR LAVAGE INFLUENCES THE SURVIVAL OF PATIENTS WITH CMV-ASSOCIATED PNEUMONIA". Paper presented in 13º Congresso Nacional de Oncologia, 2014. Nunes, Marta; Sousa, Hugo. "PNEUMONIA POR CMV EM DOENTES SUBMETIDOS A AHSCT: INFLUENCIA DA CARGA VIRAL NA SOBREVIVÊNCIA". Paper presented in Congresso Nacional de Hematologia, 2014. Lima, Aurea; Sousa, Hugo; Seabra, Vitor. "PREDICTION OF METHOTREXATE THERAPEUTIC OUTCOME: CAN AN INDEX RISK BE MORE IMPORTANT THAN A HAPLOTYPE APPROACH?". Paper presented in 7th Santorini Conference Biologie Prospective: Systems Medicine, Personalized Health and Therapy, 2014. Lima, Aurea; Sousa, Hugo; Medeiros, Rui. "ROLE OF KEY TYMS POLYMORPHISMS ON METHOTREXATE THERAPEUTIC OUTCOME IN RHEUMATOID ARTHRITIS PORTUGUESE PATIENTS". Paper presented in 7th Santorini Conference Biologie Prospective: Systems Medicine, Personalized Health and Therapy, 2014. Lima, Aurea; Seabra, Vitor; Sousa, Hugo; Medeiros, Rui. "TYMS POLYMORPHISMS AND METHOTREXATE THERAPEUTIC OUTCOME IN RHEUMATOID ARTHRITIS PORTUGUESE PATIENTS: ANALYSIS OF KEY POLYMORPHISMS". Paper presented in Annual European Congress of Rheumatology. EULAR 2014, 2014. Marinho-Dias, Joana; Ferreira, Delfim; Ribeiro, Joana; Esteves, Marlene; Loureiro, Joana; Monteiro, Paula; Baldaque, Inês; Medeiros, Rui; Sousa, Hugo. "Detection of Herpesviruses in Squamous Intraepithelial Lesions of the Cervix". Paper presented in IV Congresso Nacional de Virologia, 2013. Pereira, Carina; Queirós, Sara; Galaghar, Ana; Sousa, Hugo; Pimentel-Nunes, Pedro; Brandão, Catarina; Moreira-Dias, Luís; Medeiros, Rui; Dinis-Ribeiro, Mário. "POLYMORPHISMS IN PGE2 PATHWAY GENES AS RISK MARKERS FOR COLORECTAL CANCER DEVELOPMENT: AN OPPORTUNITY FOR TARGETED SCREENING AND/OR CHEMOPREVENTION?". Paper presented in 20th UEGW, 2012. Pereira, Carina; Sousa, Hugo; Silva, Joana; Brandão, Carla; Elgueta-Karstegl, C.; Farrell, P.J.; Medeiros, Rui; Dinis-Ribeiro, Mário. "-1195G ALLELE INCREASES THE TRANSCRIPTIONAL ACTIVITY OF COX-2 GENE: A POTENTIAL NEW MECHANISM FOR COX-2 OVEREXPRESSION IN COLORECTAL CANCER.". Paper presented in 20th UEGW, 2012. Ribeiro, Joana; Teixeira, Dulce; Dias, Joana; Baldaque, Inês; Medeiros, Rui; Sousa, Hugo. "Is HPV-16 integration a predictor marker of cervical lesions?". Paper presented in 28th International Papillomavirus Conference, 2012. Marinho-Dias, Joana; Ribeiro, Joana; Baldaque, Inês; Medeiros, Rui; Sousa, Hugo. "Prevalence of Cytomegalovirus (CMV) infection in squamous intraepithelial lesions of the cervix: is it a co-factor of HPV-associated carcinogenesis?". Paper presented in 15th annual meeting of the European Society for Clinical Virology, 2012. Teixeira, Ana Luísa; Ribeiro, Ricardo; Cardoso, Diana; Pinto, Daniela; Sousa, Hugo; Morais, António; Lobo, Francisco; et al. "Combined Functional EGF and TGFB1 Polymorphisms Influence Progression Free Survival in Androgen Blockade Treated Prostate Cancer Patients". Paper presented in ICACT 19, 2008.
Journal article	Andreia Rosário; Ana Sousa; Tatiana Varandas; Joana Marinho-Dias; Rui Medeiros; Gabriela Martins; Paula Monteiro; Hugo Sousa. "Impact of cervicovaginal microbiome on the risk of cervical abnormalities development". Journal of Medical Virology (2023): https://doi.org/10.1002/jmv.28762. 10.1002/jmv.28762 Marta Pina Fernandes; Cristina Oliveira; Hugo Sousa; Júlio Oliveira. "New Approaches in Early-Stage NSCL Management: Potential Use of PARP Inhibitors and Immunotherapy Combination". International Journal of Molecular Sciences (2023): https://doi.org/10.3390/ijms24044044. 10.3390/ijms24044044 Andreia Rosário; Sousa, Ana Saraiva; Joana Marinho-Dias; r medeiros; Cláudia Lobo; Luís Leça; Nuno Coimbra; et al. "Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program". Journal of Medical Virology 95 1 (2023): http://dx.doi.org/10.1002/jmv.28414. 10.1002/jmv.28414 Aurea Lima; Hugo Sousa; Rui Medeiros; Amanda Nobre; Manuela Machado. "PD-L1 expression in EBV associated gastric cancer: a systematic review and meta-analysis". Discover Oncology 13 1 (2022): http://dx.doi.org/10.1007/s12672-022-00479-0. 10.1007/s12672-022-00479-0 Tânia R. Dias; Francisca Dias; Ana Luísa Teixeira; Hugo Sousa; Júlio Oliveira; Rui Medeiros; Dias, Tânia R.; et al. "MicroRNAs as Potential Tools for Predicting Cancer Patients’ Susceptibility to SARS-CoV-2 Infection and Vaccination Response". Cells 11 15 (2022): 2279-2279. https://doi.org/10.3390/cells11152279. 10.3390/cells11152279 Vítor Borges; Joana Isidro; Nídia Sequeira Trovão; Sílvia Duarte; Helena Cortes Martins; HFMC Martiniano; Isabel Gordo; et al. "SARS-CoV-2 introductions and early dynamics of the epidemic in Portugal". Communications Medicine 2 1 (2022): http://dx.doi.org/10.1038/s43856-022-00072-0. 10.1038/s43856-022-00072-0 Sousa, Hugo; Salta, Sofia; Maia-Moço, Leonardo; Estevão-Pereira, Helena; Sequeira, José Pedro; Vieira, Renata; Bartosch, Carla; et al. "Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study". International Journal of Cancer 149 11 (2021): 1916-1925. http://dx.doi.org/10.1002/ijc.33778. 10.1002/ijc.33778 Eduarda Carvalho-Correia; Carla Calçada; Fernando Branca; Nuria Estévez-Gómez; Loretta De Chiara; Nair Varela; Pilar Gallego-García; et al. "OmniSARS2: A Highly Sensitive and Specific RT-qPCR-Based COVID-19 Diagnostic Method Designed to Withstand SARS-CoV-2 Lineage Evolution". Biomedicines (2021): https://doi.org/10.3390/biomedicines9101314. 10.3390/biomedicines9101314 Lima, Aurea; Sousa, Hugo; Nobre, Amanda; Faria, Ana Luisa; Machado, Manuela; Aurea Lima; Hugo Sousa; et al. "The Impact of COVID-19 Pandemic in Portuguese Cancer Patients: A Retrospective Study". International Journal of Environmental Research and Public Health 18 16 (2021): 8552. http://dx.doi.org/10.3390/ijerph18168552. 10.3390/ijerph18168552 "Association of Murine Double Minute 2 polymorphisms with gastric cancer: A systematic review with meta-analysis". Biomedical Reports 15 2 (2021): http://dx.doi.org/10.3892/br.2021.1445. 10.3892/br.2021.1445 Foteini Roumani; Sarah Azinheiro; Hugo Sousa; Ana Sousa; Mafalda Timóteo; Tatiana Varandas; Daniela Fonseca-Silva; et al. "Optimization and Clinical Evaluation of a Multi-Target Loop-Mediated Isothermal Amplification Assay for the Detection of SARS-CoV-2 in Nasopharyngeal Samples". Viruses 13 5 (2021): 940-940. https://doi.org/10.3390/v13050940. 10.3390/v13050940 Isabel Castro; Belém Sampaio-Marques; Anabela C. Areias; Hugo Sousa; Ângela Fernandes; José Manuel Sanchez-Maldonado; Cristina Cunha; et al. "Functional Genetic Variants in ATG10 Are Associated with Acute Myeloid Leukemia". Cancers 13 6 (2021): 1344-1344. https://doi.org/10.3390/cancers13061344. 10.3390/cancers13061344 López-Labrador, F. Xavier; Brown, Julianne R.; Fischer, Nicole; Harvala, Heli; Van Boheemen, Sander; Cinek, Ondrej; Sayiner, Arzu; et al. "Recommendations for the introduction of metagenomic high-throughput sequencing in clinical virology, part I: Wet lab procedure". Journal of Clinical Virology 134 (2021): 104691. http://dx.doi.org/10.1016/j.jcv.2020.104691. 10.1016/j.jcv.2020.104691 Gonçalves, Helena M.; Silva, Jani; Pintado Maury, Inês; Tavares, Ana; Campos, Carla; Sousa, Hugo; Jacinto, Amado; et al. "The prevalence and risk-factors of oral HPV DNA detection among HIV-infected men between men who have sex with men and heterosexual men". Infectious Diseases 53 1 (2020): 19-30. http://dx.doi.org/10.1080/23744235.2020.1811373. 10.1080/23744235.2020.1811373 Sousa, Hugo. "Human papillomavirus prevalence and distribution in self-collected samples from female university students in Maputo". International Journal of Gynecology & Obstetrics 149 2 (2020): 237-246. http://dx.doi.org/10.1002/ijgo.13126. 10.1002/ijgo.13126 Borges, Vítor; Isidro, Joana; Cortes-Martins, Helena; Duarte, Sílvia; Vieira, Luís; Leite, Ricardo; Gordo, Isabel; et al. "Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal". Emerging Microbes & Infections 9 1 (2020): 2488-2496. http://dx.doi.org/10.1080/22221751.2020.1844552. 10.1080/22221751.2020.1844552 Sousa, Hugo; Tavares, Ana; Campos, Carla; Marinho-Dias, Joana; Brito, Margarida; Medeiros, Rui; Baldaque, Inês; et al. "High-Risk human papillomavirus genotype distribution in the Northern region of Portugal: Data from regional cervical cancer screening program". Papillomavirus Research 8 (2019): 100179. http://dx.doi.org/10.1016/j.pvr.2019.100179. 10.1016/j.pvr.2019.100179 Ribeiro, Joana; Malta, Mariana; Galaghar, Ana; Afonso, Luís Pedro; Libânio, Diogo; Medeiros, Rui; Dinis-Ribeiro, Mario; Pimentel-Nunes, Pedro; Sousa, Hugo. "Epstein-Barr virus is absent in gastric superficial neoplastic lesions". Virchows Archiv 475 6 (2019): 757-762. http://dx.doi.org/10.1007/s00428-019-02670-1. 10.1007/s00428-019-02670-1 Sara Cruz; Carla Campos; Mafalda Timóteo; Ana Tavares; Maria São José Nascimento; Rui Medeiros; Hugo Sousa. "Hepatitis E virus in hematopoietic stem cell transplant recipients: A systematic review". Journal of Clinical Virology 119 (2019): 31-36. https://doi.org/10.1016/j.jcv.2019.08.002. 10.1016/j.jcv.2019.08.002 Marinho-Dias, J.; Baldaque, I.; Pinho-Vaz, C.; Leite, L.; Branca, R.; Campilho, F.; Campos, A.; Medeiros, R.; Sousa, H.. "Association of Epstein-Barr virus infection with allogeneic hematopoietic stem cell transplantation in patients in Portugal". Molecular Medicine Reports 19 3 (2019): 1435-1442. http://www.scopus.com/inward/record.url?eid=2-s2.0-85061159400&partnerID=MN8TOARS. 10.3892/mmr.2018.9794 Araujo, R.; Santos, J. M. O.; Fernandes, M.; Dias, F.; Sousa, H.; Ribeiro, J.; Bastos, Mmsm; et al. "Expression profile of microRNA-146a along HPV-induced multistep carcinogenesis: a study in HPV16 transgenic mice". J Cancer Res Clin Oncol 144 2 (2018): 241-248. https://www.ncbi.nlm.nih.gov/pubmed/29181576. 10.1007/s00432-017-2549-5 Farinha, M.; Ribeiro, J.; Montezuma, D.; Pires-Luís, A.; Lopes, P.; Sousa, H.; Afonso, L.; Henrique, R.. "Correction to: Abstracts: 29th European Congress of Pathology (Virchows Archiv, (2017), 471, S1, (1-352), 10.1007/s00428-017-2205-0)". Virchows Archiv 472 2 (2018): 303-303. http://www.scopus.com/inward/record.url?eid=2-s2.0-85034046221&partnerID=MN8TOARS. 10.1007/s00428-017-2254-4 Marinho-Dias, J.; Lobo, J.; Henrique, R.; Baldaque, I.; Pinho-Vaz, C.; Regadas, L.; Branca, R.; et al. "Post-transplant lymphoproliferative disorder in hematopoietic stem cell transplant patients: A single center retrospective study between 2005 and 2012". Molecular Medicine Reports 18 5 (2018): 4650-4656. http://www.scopus.com/inward/record.url?eid=2-s2.0-85053843007&partnerID=MN8TOARS. 10.3892/mmr.2018.9433 Moutinho, M.S.S.; Aragão, S.; Carmo, D.; Casaca, F.; Silva, S.; Ribeiro, J.; Sousa, H.; et al. "Curcumin and rutin down-regulate cyclooxygenase-2 and reduce tumor-associated inflammation in HPV16-transgenic mice". Anticancer Research 38 3 (2018): 1461-1466. http://www.scopus.com/inward/record.url?eid=2-s2.0-85043432639&partnerID=MN8TOARS. 10.21873/anticanres.12371 Ribeiro, Joana; Malta, Mariana; Galaghar, Ana; Silva, Fernanda; Afonso, Luís Pedro; Medeiros, Rui; Sousa, Hugo. "P53 deregulation in Epstein-Barr virus-associated gastric cancer". Cancer Letters 404 (2017): 37-43. http://dx.doi.org/10.1016/j.canlet.2017.07.010. 10.1016/j.canlet.2017.07.010 Ribeiro, Joana; Oliveira, Cláudia; Malta, Mariana; Sousa, Hugo. "Epstein–Barr virus gene expression and latency pattern in gastric carcinomas: a systematic review". Future Oncology 13 6 (2017): 567-579. http://dx.doi.org/10.2217/fon-2016-0475. 10.2217/fon-2016-0475 Campos, Ana Bela; Ribeiro, Joana; Pinho Vaz, Carlos; Campilho, Fernando; Branca, Rosa; Campos, António; Baldaque, Inês; et al. "Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study". Antiviral Research 138 (2017): 86-92. http://dx.doi.org/10.1016/j.antiviral.2016.10.016. 10.1016/j.antiviral.2016.10.016 Da Costa, R.M.G.; Araujo, R.; Santos, J.M.O.; Fernandes, M.; Neto, T.; Sousa, H.; Ribeiro, J.; et al. "Regulation of miRNA-146a and miRNA-150 Levels by celecoxib in premalignant lesions of K14-HPV16 mice". Anticancer Research 37 6 (2017): 2913-2918. http://www.scopus.com/inward/record.url?eid=2-s2.0-85019702645&partnerID=MN8TOARS. 10.21873/anticanres.11644 Santos, J.M.O.; Fernandes, M.; Araújo, R.; Sousa, H.; Ribeiro, J.; Bastos, M.M.S.M.; Oliveira, P.A.; et al. "Dysregulated expression of microRNA-150 in human papillomavirus-induced lesions of K14-HPV16 transgenic mice". Life Sciences 175 (2017): 31-36. http://www.scopus.com/inward/record.url?eid=2-s2.0-85016497356&partnerID=MN8TOARS. 10.1016/j.lfs.2017.03.008 Neves, M.; Marinho-Dias, J.; Ribeiro, J.; Sousa, H.. "Epstein–Barr virus strains and variations: Geographic or disease-specific variants?". Journal of Medical Virology 89 3 (2017): 373-387. http://www.scopus.com/inward/record.url?eid=2-s2.0-85006928799&partnerID=MN8TOARS. 10.1002/jmv.24633 Ribeiro, J.; Oliveira, A.; Malta, M.; Oliveira, C.; Silva, F.; Galaghar, A.; Afonso, L.P.; et al. "Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal". World Journal of Gastroenterology 23 40 (2017): 7292-7302. http://www.scopus.com/inward/record.url?eid=2-s2.0-85032989236&partnerID=MN8TOARS. 10.3748/wjg.v23.i40.7292 Gil da Costa, R.M.; Aragão, S.; Moutinho, M.; Alvarado, A.; Carmo, D.; Casaca, F.; Silva, S.; et al. "HPV16 induces a wasting syndrome in transgenic mice: Amelioration by dietary polyphenols via NF-¿B inhibition". Life Sciences 169 (2017): 11-19. http://www.scopus.com/inward/record.url?eid=2-s2.0-85008339572&partnerID=MN8TOARS. 10.1016/j.lfs.2016.10.031 Santos, Carlos; Ferreirinha, Pedro; Sousa, Hugo; Ribeiro, Joana; Bastos, Margarida M.S.M.; Neto, Tiago; Oliveira, Paula A.; et al. "Ptaquiloside from bracken (Pteridium spp.) inhibits tumour-infiltrating CD8+ T cells in HPV-16 transgenic mice". Food and Chemical Toxicology 97 (2016): 277-285. http://dx.doi.org/10.1016/j.fct.2016.09.019. 10.1016/j.fct.2016.09.019 Neves, Marco; Ribeiro, Joana; Medeiros, Rui; Sousa, Hugo. "Genetic polymorphism in DNMTs and gastric cancer: A systematic review and meta-analysis". Porto Biomedical Journal 1 5 (2016): 164-172. http://dx.doi.org/10.1016/j.pbj.2016.10.005. 10.1016/j.pbj.2016.10.005 Pereira, Carina; Queirós, Sara; Galaghar, Ana; Sousa, Hugo; Marcos-Pinto, Ricardo; Pimentel-Nunes, Pedro; Brandão, Catarina; Medeiros, Rui; Dinis-Ribeiro, Mário. "Influence of Genetic Polymorphisms in Prostaglandin E2 Pathway (COX-2/HPGD/SLCO2A1/ABCC4) on the Risk for Colorectal Adenoma Development and Recurrence after Polypectomy". Clinical and Translational Gastroenterology 7 9 (2016): e191. http://dx.doi.org/10.1038/ctg.2016.47. 10.1038/ctg.2016.47 Campos, Ana Bela; Ribeiro, Joana; Boutolleau, David; Sousa, Hugo. "Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art". Reviews in Medical Virology 26 3 (2016): 161-182. http://dx.doi.org/10.1002/rmv.1873. 10.1002/rmv.1873 Sousa, H; Bastos, MJ; Ribeiro, J; Oliveira, S; Breda, E; Catarino, R; Medeiros, R. "5'UTR +24T>C CR2 is not associated with nasopharyngeal carcinoma development in the North Region of Portugal". Oral Diseases 22 4 (2016): 280-284. http://dx.doi.org/10.1111/odi.12436. 10.1111/odi.12436 Sousa, Hugo; Mesquita, Letícia; Ribeiro, Joana; Catarino, Raquel; Breda, Eduardo; Medeiros, Rui. "Polymorphisms in host immune response associated genes and risk of nasopharyngeal carcinoma development in Portugal". Immunobiology 221 2 (2016): 145-152. http://dx.doi.org/10.1016/j.imbio.2015.09.015. 10.1016/j.imbio.2015.09.015 Santos, C.; Neto, T.; Ferreirinha, P.; Sousa, H.; Ribeiro, J.; Bastos, M.M.S.M.; Faustino-Rocha, A.I.; et al. "Celecoxib promotes degranulation of CD8⁺T cells in HPV-induced lesions of K14-HPV16 transgenic mice". Life Sciences 157 (2016): 67-73. http://www.scopus.com/inward/record.url?eid=2-s2.0-84974678418&partnerID=MN8TOARS. 10.1016/j.lfs.2016.05.040 Malta, M.; Ribeiro, J.; Monteiro, P.; Loureiro, J.; Medeiros, R.; Sousa, H.. "Let-7c is a Candidate Biomarker for Cervical Intraepithelial Lesions: A Pilot Study". Mol Diagn Ther 19 3 (2015): 191-6. https://www.ncbi.nlm.nih.gov/pubmed/26063583. 10.1007/s40291-015-0145-4 10.1007/s40291-015-0145-4. Ribeiro, Joana; Ferreira, Delfim; Arrabalde, Célia; Almeida, Sandra; Baldaque, Inês; Sousa, Hugo. "Prevalence of adenovirus and rotavirus infection in immunocompromised patients with acute gastroenteritis in Portugal". World Journal of Virology 4 4 (2015): 372. http://dx.doi.org/10.5501/wjv.v4.i4.372. 10.5501/wjv.v4.i4.372 Neves, M.; Marinho-Dias, J.; Ribeiro, J.; Esteves, M.; Maltez, E.; Baldaque, I.; Breda, E.; et al. "Characterization of Epstein-Barr virus strains and LMP1-deletion variants in Portugal". Journal of Medical Virology 87 8 (2015): 1382-1388. http://www.scopus.com/inward/record.url?eid=2-s2.0-84930375384&partnerID=MN8TOARS. 10.1002/jmv.24190 Paiva, I.; Da Costa, R.M.G.; Ribeiro, J.; Sousa, H.; Bastos, M.; Rocha, A.F.C.; Oliveira, P.A.; Medeiros, R.. "A role for MicroRNA-155 expression in microenvironment associated to HPV-induced carcinogenesis in K14-HPV16 transgenic mice". PLoS ONE 10 1 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84921957587&partnerID=MN8TOARS. 10.1371/journal.pone.0116868 Paiva, I.; Gil Da Costa, R.M.; Ribeiro, J.; Sousa, H.; Bastos, M.M.S.M.; Faustino-Rocha, A.; Lopes, C.; Oliveira, P.A.; Medeiros, R.. "MicroRNA-21 expression and susceptibility to HPV-induced carcinogenesis - Role of microenvironment in K14-HPV16 mice model". Life Sciences 128 (2015): 8-14. http://www.scopus.com/inward/record.url?eid=2-s2.0-84925071316&partnerID=MN8TOARS. 10.1016/j.lfs.2015.02.020 Ribeiro, J.; Marinho-Dias, J.; Monteiro, P.; Loureiro, J.; Baldaque, I.; Medeiros, R.; Sousa, H.. "MiR-34a and miR-125b expression in HPV infection and cervical cancer development". BioMed Research International 2015 (2015): http://www.scopus.com/inward/record.url?eid=2-s2.0-84934950348&partnerID=MN8TOARS. 10.1155/2015/304584 Sousa, Hugo; Boutolleau, David; Ribeiro, Joana; Teixeira, Ana L.; Pinho Vaz, Carlos; Campilho, Fernando; Branca, Rosa; et al. "Cytomegalovirus Infection in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation in Portugal: A Five-Year Retrospective Review". Biology of Blood and Marrow Transplantation 20 12 (2014): 1958-1967. http://dx.doi.org/10.1016/j.bbmt.2014.08.010. 10.1016/j.bbmt.2014.08.010 Azevedo, Ana Rita Pereira; Sousa, Hugo; Monteiro, Joaquim António Faria; Lima, Aurea Rosa Nunes Pereira. "Future perspectives of Smartphone applications for rheumatic diseases self-management". Rheumatology International 35 3 (2014): 419-431. http://dx.doi.org/10.1007/s00296-014-3117-9. 10.1007/s00296-014-3117-9 Lima, Aurea; Bernardes, Miguel; Azevedo, Rita; Monteiro, Joaquim; Sousa, Hugo; Medeiros, Rui; Seabra, Vítor. "SLC19A1, SLC46A1 and SLCO1B1 Polymorphisms as Predictors of Methotrexate-Related Toxicity in Portuguese Rheumatoid Arthritis Patients". Toxicological Sciences 142 1 (2014): 196-209. http://dx.doi.org/10.1093/toxsci/kfu162. 10.1093/toxsci/kfu162 Ribeiro, Joana; Sousa, Hugo. "MicroRNAs as biomarkers of cervical cancer development: a literature review on miR-125b and miR-34a". Molecular Biology Reports 41 3 (2014): 1525-1531. http://dx.doi.org/10.1007/s11033-013-2998-0. 10.1007/s11033-013-2998-0 Fraga, Avelino; Ribeiro, Ricardo; Príncipe, Paulo; Lobato, Carlos; Pina, Francisco; Maurício, Joaquina; Monteiro, Cátia; et al. "The HIF1A functional genetic polymorphism at locus +1772 associates with progression to metastatic prostate cancer and refractoriness to hormonal castration". European Journal of Cancer 50 2 (2014): 359-365. http://dx.doi.org/10.1016/j.ejca.2013.09.001. 10.1016/j.ejca.2013.09.001 Lima, A.; Bernardes, M.; Sousa, H.; Azevedo, R.; Costa, L.; Ventura, F.; Seabra, V.; Medeiros, R.. "SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients". Pharmacogenomics 15 6 (2014): 807-820. http://www.scopus.com/inward/record.url?eid=2-s2.0-84896373858&partnerID=MN8TOARS. 10.2217/PGS.13.244 Lima, A.; Sousa, H.; Monteiro, J.; Azevedo, R.; Medeiros, R.; Seabra, V.. "Genetic polymorphisms in low-dose methotrexate transporters: Current relevance as methotrexate therapeutic outcome biomarkers". Pharmacogenomics 15 12 (2014): 1611-1635. http://www.scopus.com/inward/record.url?eid=2-s2.0-84908131959&partnerID=MN8TOARS. 10.2217/pgs.14.116 Lima, A.; Monteiro, J.; Bernardes, M.; Sousa, H.; Azevedo, R.; Seabra, V.; Medeiros, R.. "Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: Implication of MTHFR RS1801133 and ATIC RS4673993 polymorphisms". BioMed Research International 2014 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84902174947&partnerID=MN8TOARS. 10.1155/2014/368681 Lima, A.; Seabra, V.; Bernardes, M.; Azevedo, R.; Sousa, H.; Medeiros, R.. "Role of key TYMSPolymorphisms on methotrexate therapeutic outcome in Portuguese rheumatoid arthritis patients". PLoS ONE 9 10 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84908619242&partnerID=MN8TOARS. 10.1371/journal.pone.0108165 Pereira, C.; Queiros, S.; Galaghar, A.; Sousa, H.; Pimentel-Nunes, P.; Brandão, C.; Moreira-Dias, L.; Medeiros, R.; Dinis-Ribeiro, M.. "Genetic variability in key genes in prostaglandin e2 pathway (COX-2, HPGD, ABCC4 and SLCO2A1) and their involvement in colorectal cancer development". PLoS ONE 9 4 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84898827962&partnerID=MN8TOARS. 10.1371/journal.pone.0092000 Ribeiro, J.; Teixeira, D.; Marinho-Dias, J.; Monteiro, P.; Loureiro, J.; Baldaque, I.; Medeiros, R.; Sousa, H.. "Characterization of human papillomavirus genotypes and HPV-16 physical status in cervical neoplasias of women from northern Portugal". International Journal of Gynecology and Obstetrics 125 2 (2014): 107-110. http://www.scopus.com/inward/record.url?eid=2-s2.0-84897572092&partnerID=MN8TOARS. 10.1016/j.ijgo.2013.10.011 Sousa, Hugo; Oliveira, Sara; Santos, Alexandra M.; Catarino, Raquel; Moutinho, José; Medeiros, Rui. "Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to invasive cervical cancer". Tumor Biology 35 3 (2013): 2561-2564. http://dx.doi.org/10.1007/s13277-013-1337-3. 10.1007/s13277-013-1337-3 Sousa, Hugo; Breda, Eduardo; Santos, Alexandra M.; Catarino, Raquel; Pinto, Daniela; Canedo, Paulo; Machado, José Carlos; Medeiros, Rui. "IL-1RN VNTR polymorphism as a susceptibility marker for nasopharyngeal carcinoma in Portugal". Archives of Oral Biology 58 8 (2013): 1040-1046. http://dx.doi.org/10.1016/j.archoralbio.2013.02.004. 10.1016/j.archoralbio.2013.02.004 Pereira, Carina; Sousa, Hugo; Silva, Joana; Brandão, Carla; Elgueta-Karstegl, Claudio; Farrell, Paul J.; Medeiros, Rui; Dinis-Ribeiro, Mário. "The -1195G allele increases the transcriptional activity of cyclooxygenase-2 gene (COX-2) in colon cancer cell lines". Molecular Carcinogenesis 53 S1 (2013): E92-E95. http://dx.doi.org/10.1002/mc.22049. 10.1002/mc.22049 Silva, Jani; Cerqueira, Fátima; Ribeiro, Joana; Sousa, Hugo; Osório, Teresa; Medeiros, Rui. "Is Chlamydia trachomatis related to human papillomavirus infection in young women of southern European population? A self-sampling study". Archives of Gynecology and Obstetrics 288 3 (2013): 627-633. http://dx.doi.org/10.1007/s00404-013-2771-6. 10.1007/s00404-013-2771-6 Marinho-Dias, J.; Sousa, Hugo. "Cytomegalovirus infection and cervical cancer: from past doubts to present questions". Acta Medica Portuguesa 26 2 (2013): 154-160. http://www.scopus.com/inward/record.url?eid=2-s2.0-84878856574&partnerID=MN8TOARS. Published Marinho-Dias, J.; Ribeiro, J.; Monteiro, P.; Loureiro, J.; Baldaque, I.; Medeiros, R.; Sousa, H.. "Characterization of cytomegalovirus and epstein-barr virus infection in cervical lesions in Portugal". Journal of Medical Virology 85 8 (2013): 1409-1413. http://www.scopus.com/inward/record.url?eid=2-s2.0-84879145608&partnerID=MN8TOARS. 10.1002/jmv.23596 Lima, A.; Azevedo, R.; Sousa, H.; Seabra, V.; Medeiros, R.. "Current approaches for TYMS polymorphisms and their importance in molecular epidemiology and pharmacogenetics". Pharmacogenomics 14 11 (2013): 1337-1351. http://www.scopus.com/inward/record.url?eid=2-s2.0-84882241312&partnerID=MN8TOARS. 10.2217/pgs.13.118 Sousa, Hugo; Santos, Alexandra M.; Catarino, Raquel; Pinto, Daniela; Moutinho, José; Canedo, Paulo; Machado, José Carlos; Medeiros, Rui. "IL-1RN VNTR polymorphism and genetic susceptibility to cervical cancer in Portugal". Molecular Biology Reports 39 12 (2012): 10837-10842. http://dx.doi.org/10.1007/s11033-012-1979-z. 10.1007/s11033-012-1979-z Craveiro, Rogéria; Bravo, Isabel; Catarino, Raquel; Teixeira, Ana Luisa; Sousa, Hugo; Pereira, Deolinda; Pereira, Helena; Medeiros, Rui. "The Role of p73 G4C14-to-A4T14 Polymorphism in the Susceptibility to Cervical Cancer". DNA and Cell Biology 31 2 (2012): 224-229. http://dx.doi.org/10.1089/dna.2011.1294. 10.1089/dna.2011.1294 OLIVEIRA, S.; RIBEIRO, J.; Sousa, Hugo; PINTO, D.; BALDAQUE, I.; MEDEIROS, R.. "Genetic polymorphisms and cervical cancer development: ATM G5557A and p53bp1 C1236G". Oncology Reports 27 4 (2011): 1188-1192. http://dx.doi.org/10.3892/or.2011.1609. 10.3892/or.2011.1609 Sousa, Hugo; Breda, Eduardo; Santos, Alexandra M.; Catarino, Raquel; Pinto, Daniela; Medeiros, Rui. "Genetic Risk Markers for Nasopharyngeal Carcinoma in Portugal: Tumor Necrosis Factor Alpha¿-308G¿>A Polymorphism". DNA and Cell Biology 30 2 (2011): 99-103. http://dx.doi.org/10.1089/dna.2010.1086. 10.1089/dna.2010.1086 Silva, Jani; Ribeiro, Joana; Sousa, Hugo; Cerqueira, Fátima; Teixeira, Ana Luisa; Baldaque, Ines; Osório, Teresa; Medeiros, Rui. "Oncogenic HPV Types Infection in Adolescents and University Women from North Portugal: From Self-Sampling to Cancer Prevention". Journal of Oncology 2011 (2011): 1-8. http://dx.doi.org/10.1155/2011/953469. 10.1155/2011/953469 Sousa, H.; Santos, A. M.; Pinto, D.; Medeiros, R.. "Is there a biological plausability for p53 codon 72 polymorphism influence on cervical cancer development?". Acta Med Port 24 1 (2011): 127-34. https://www.ncbi.nlm.nih.gov/pubmed/21672450. Sousa, H.; Silva, J.; Azevedo, L.; Pinto-Correia, A. L.; Catarino, R.; Pinto, D.; Lopes, C.; Medeiros, R.. "Epstein-Barr virus in healthy individuals from Portugal". Acta Med Port 24 5 (2011): 707-12. http://www.ncbi.nlm.nih.gov/pubmed/22525621. Sousa, H.; Santos, A.M.; Pinto, D.; Medeiros, R.. "Is there a biological plausability for p53 codon 72 polymorphism influence on cervical cancer development?,Existem evidências biológicas do papel do poliforfismo no codão 72 da p53 na suscepstibilidade para cancro do colo do útero". Acta Medica Portuguesa 24 1 (2011): 127-134. http://www.scopus.com/inward/record.url?eid=2-s2.0-79953276262&partnerID=MN8TOARS. Sousa, H.; Silva, J.; Azevedo, L.; Pinto-Correia, A.L.; Catarino, R.; Pinto, D.; Lopes, C.; Medeiros, R.. "Epstein-Barr virus in healthy individuals from Portugal,Caracterização da frequência do vírus de Epstein-Barr em dadores saudáveis de Portugal". Acta Medica Portuguesa 24 5 (2011): 707-712. http://www.scopus.com/inward/record.url?eid=2-s2.0-84857146134&partnerID=MN8TOARS. Sousa, Hugo; Pando, Mafalda; Breda, Eduardo; Catarino, Raquel; Medeiros, Rui. "Role of the MDM2 SNP309 polymorphism in the initiation and early age of onset of nasopharyngeal carcinoma". Molecular Carcinogenesis 50 2 (2010): 73-79. http://dx.doi.org/10.1002/mc.20689. 10.1002/mc.20689 Pinto-Correia, Ana L.; Pinto, Daniela; Pereira, Deolinda; Rodrigues, Helena; de Sousa, Joaquim Abreu; Sousa, Hugo; Sousa, Berta; et al. "Overall Survival in Women with Breast Cancer: The Influence of Pepsinogen C Gene Polymorphism". DNA and Cell Biology 27 6 (2008): 333-336. http://dx.doi.org/10.1089/dna.2007.0713. 10.1089/dna.2007.0713 Sousa, Hugo; Pinto-Correia, Ana L; Medeiros, Rui; Dinis-Ribeiro, Mario. "Epstein-Barr virus is associated with gastric carcinoma: The question is what is the significance?". World Journal of Gastroenterology 14 27 (2008): 4347. http://dx.doi.org/10.3748/wjg.14.4347. 10.3748/wjg.14.4347 Oliveira, Sara; Sousa, Hugo; Pinto, Daniela; Pinto-Correia, AL; Moutinho, J.; Medeiros, Rui. "The influence of the Ataxia-Telangiectasia mutated G5557A polymorphism on cervical cancer development". Ejc Supplements 6 9 (2008): 51-51. Published Oliveira, S.; Sousa, H.; Santos, A.M.; Pinto, D.; Pinto-Correia, A.L.; Fontoura, D.; Moutinho, J.; Medeiros, R.. "The p53 R72P polymorphism does not influence cervical cancer development in a portuguese population: A study in exfoliated cervical cells". Journal of Medical Virology 80 3 (2008): 424-429. http://dx.doi.org/10.1002/jmv.21103. 10.1002/jmv.21103 Breda, E.; Catarino, R.; Coelho, A.; Sousa, H.; Medeiros, R.. "Nasopharyngeal carcinoma study: Introduction and multidisciplinary perspective". Acta Med Port 21 3 (2008): 273-84. https://www.ncbi.nlm.nih.gov/pubmed/18674419. Breda, E.; Catarino, R.; Coelho, A.; Sousa, H.; Medeiros, R.. "Nasopharyngeal carcinoma study: Introduction and multidisciplinary perspective,Estudo do carcinoma de tipo nasofaringeo: Introdução e perspectiva multidisciplinar". Acta Medica Portuguesa 21 1-3 (2008): 273-284. http://www.scopus.com/inward/record.url?eid=2-s2.0-51349083239&partnerID=MN8TOARS. Santos, Alexandra; Pinto, Daniela; Medeiros, Rui; Sousa, Hugo; Sousa, H.; Santos, A.M.; Pinto, D.; Medeiros, R.. "Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations". International Journal of Molecular Medicine 20 5 (2007): 731-741. http://dx.doi.org/10.3892/ijmm.20.5.731. 10.3892/ijmm.20.5.731 Coelho, Ana; Matos, Ana; Catarino, Raquel; Pinto, Daniela; Sousa, Hugo; Pereira, Deolinda; Medeiros, Rui. "The Influence of Chemokine Receptor CCR2 Genotypes in the Route to Cervical Carcinogenesis". Gynecologic and Obstetric Investigation 64 4 (2007): 208-212. http://dx.doi.org/10.1159/000106492. 10.1159/000106492 Sousa, Hugo; Santos, Alexandra M.; Catarino, Raquel; Pinto, Daniela; Vasconcelos, Andre´; Lopes, Carlos; Breda, Eduardo; Medeiros, Rui. "Linkage of TP53 codon 72 pro/pro genotype as predictive factor for nasopharyngeal carcinoma development". European Journal of Cancer Prevention 15 4 (2006): 362-366. http://dx.doi.org/10.1097/00008469-200608000-00010. 10.1097/00008469-200608000-00010 Santos, Alexandra M.; Sousa, Hugo; Pinto, Daniela; Portela, Catarina; Pereira, Deolinda; Catarino, Raquel; Duarte, Isabel; Lopes, Carlos; Medeiros, Rui. "Linking TP53 codon 72 and P21 nt590 genotypes to the development of cervical and ovarian cancer". European Journal of Cancer 42 7 (2006): 958-963. http://dx.doi.org/10.1016/j.ejca.2006.01.015. 10.1016/j.ejca.2006.01.015 Catarino, Raquel J.; Breda, Eduardo; Coelho, Vânia; Pinto, Daniela; Sousa, Hugo; Lopes, Carlos; Medeiros, Rui. "Association of the A870G cyclin D1 gene polymorphism with genetic susceptibility to nasopharyngeal carcinoma". Head & Neck 28 7 (2006): 603-608. http://dx.doi.org/10.1002/hed.20377. 10.1002/hed.20377 Pereira, Carina; Sousa, Hugo; Ferreira, Paula; Fragoso, Maria; Moreira-Dias, L.; Lopes, Carlos; Medeiros, Rui; Dinis-Ribeiro, Mário. "-765G > CCOX-2polymorphism may be a susceptibility marker for gastric adenocarcinoma in patients with atrophy or intestinal metaplasia". World Journal of Gastroenterology 12 34 (2006): 5473. http://dx.doi.org/10.3748/wjg.v12.i34.5473. 10.3748/wjg.v12.i34.5473 Pinto-Correia, A.L.; Sousa, H.; Fragoso, M.; Moreira-Dias, L.; Lopes, C.; Medeiros, R.; Dinis-Ribeiro, M.. "Gastric cancer in a Caucasian population: Role of pepsinogen C genetic variants". World Journal of Gastroenterology 12 31 (2006): 5033-5036. http://www.scopus.com/inward/record.url?eid=2-s2.0-33748312255&partnerID=MN8TOARS. 10.3748/wjg.v12.i31.5033 Santos, A.M.; Sousa, H.; Portela, C.; Pereira, D.; Pinto, D.; Catarino, R.; Rodrigues, C.; et al. "TP53 and P21 polymorphisms: Response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer". Biochemical and Biophysical Research Communications 340 1 (2006): 256-262. http://www.scopus.com/inward/record.url?eid=2-s2.0-29244474068&partnerID=MN8TOARS. 10.1016/j.bbrc.2005.11.176 Santos, Alexandra M.; Sousa, Hugo; Catarino, Raquel; Pinto, Daniela; Pereira, Deolinda; Vasconcelos, André; Matos, Ana; Lopes, Carlos; Medeiros, Rui. "TP53 codon 72 polymorphism and risk for cervical cancer in Portugal". Cancer Genetics and Cytogenetics 159 2 (2005): 143-147. http://dx.doi.org/10.1016/j.cancergencyto.2004.10.005. 10.1016/j.cancergencyto.2004.10.005 Duarte, I.; Santos, A.; Sousa, H.; Catarino, R.; Pinto, D.; Matos, A.; Pereira, D.; et al. "G-308A TNF-a polymorphism is associated with an increased risk of invasive cervical cancer". Biochemical and Biophysical Research Communications 334 2 (2005): 588-592. http://www.scopus.com/inward/record.url?eid=2-s2.0-22144439398&partnerID=MN8TOARS. 10.1016/j.bbrc.2005.06.137
Online resource	Sousa, Hugo. DOUTOR URGENTE. 2018. https://doutorurgente.blogspot.com/.
Thesis / Dissertation	Cruz, Sara Manuela Gonçalves. "Hepatitis e virus in hematopoietic stem cell transplant recipients". Master, 2020. http://hdl.handle.net/10400.14/31507. Oliveira, Andreia Fernanda Nora de. "Characterization of EBV-associated gastric cancers". Master, 2015. http://hdl.handle.net/10400.14/20133. Sousa, Hugo. "CMV INFECTION IN HEMATOPOIETIC STEM CELL TRANSPLANTED PATIENTS FROM PORTUGAL: A 5-YEAR REVIEW". Master, Universidade do Porto Faculdade de Medicina, 2014. Hugo Manuel Lopes de Sousa. "Cytomegalovirus infection in bone marrow trasplanted patients from Portugal: a 5-year retrospestive review". Master, 2014. https://hdl.handle.net/10216/89912. Dias, Joana Sousa Gonçalves de Marinho. "Characterization of herpesvirus infection in cervico-vaginal samples : role in cervical cancer". Master, 2012. http://hdl.handle.net/10400.14/21003. Sousa, Hugo. "ONCOVIROGENOMICS: GENETIC SUSCEPTIBILITY TO VIRAL ASSOCIATED NEOPLASIAS". PhD, Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, 2011. Sousa, Hugo. "ROLE OF EBNA2 IN EBV ASSOCIATED C-MYC ACTIVATION". Master, Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, 2005.

Activities

Oral presentation

	Presentation title	Event name Host (Event location)
2020/02	MDM2 EXPRESSION IN EPSTEIN-BARR VIRUS-ASSOCIATED GASTRIC CANCERS	IJUP 2020 Universidade do Porto (Portugal)
2019/04/27	PREVENÇÃO DE CANCRO	ABADE DE NEIVA SAUDÁVEL DELEGAÇÃO DE BARCELOS - LIGA PORTUGUESA CONTRA O CANCRO NRN (ABADE DE NEIVA - BARCELOS, Portugal)
2019	HIGH PREVALENCE OF HIGH-RISK HPV INFECTION IN UNIVERSITY STUDENTS FROM THE NORTHEAST REGION OF PORTUGAL USING SELF-SAMPLING	22nd European Society for Clinical Virology's Annual Meeting European Society for Clinical Virology (Denmark)
2019	EPSTEIN-BARR VIRUS IS ABSENT IN GASTRIC SUPERFICIAL NEOPLASTIC LESIONS: A RETROSPECTIVE STUDY	22nd European Society for Clinical Virology's Annual Meeting European Society for Clinical Virology (Denmark)
2018/10	HUMAN PAPILLOMAVIRUS GENOTYPING IN CERVICAL CANCER SCREENING: DATA FROM THE NORTH REGION OF PORTUGAL	IPVC 2018 Seegene (Sidney, Australia)
2017/10	EBV IS A LATE EVENT OF GASTRIC CARCINOGENESIS	13º Congresso Nacional Cancro Digestivo (Albufeira, Portugal)
2016/09	EPSTEIN-BARR VIRUS ASSOCIATED GASTRIC CARCINOMAS IN PORTUGAL	ESP 2016 (XXXI International Congress of the International Academy of Pathology and the 28th Congress of the European Society of Pathology) (Colónia, Germany)
2016	DETECÇÃO DO ALELO E (310PB) DO GENE DO PGC COMO FACTOR PROTECTOR PARA DESENVOLVIMENTO DE LESÕES ASSOCIADAS A CARCINOMAS GÁSTRICOS	Congresso Nacional de Gastrenterologia (Portugal)
2015/09	MICRORNA-155 AND MICRORNA-21 EXPRESSION IN K14-HPV16 TRANSGENIC MICE: IMPLICATIONS IN HPV-INDUCED CARCINOGENESIS	IPVC 2015 IPVS (Lisboa, Portugal)
2014/11	MDM2 SNP309 TT HOMOZYGOUS ARE ASSOCIATED WITH INCREASED RISK OF COLORECTAL CANCER DEVELOPMENT	13th National Congress of Oncology (Porto, Portugal)
2014/11	EBV-ASSOCIATED GASTRIC CARCINOMAS IN PORTUGAL	13th National Congress of Oncology (Porto, Portugal)
2014/02	LET-7C EXPRESSION IN HPV-ASSOCIATED CERVICAL LESIONS AND CANCER	IJUP2014 (Porto, Portugal)
2014/02	MDM2 SNP309 TT HOMOZYGOUS ARE ASSOCIATED WITH INCREASED RISK OF COLORECTAL CANCER DEVELOPMENT	IJUP2014
2014/02	PREVALENCE OF HUMAN PAPILLOMAVIRUS IN TISSUE SAMPLES FROM HEAD AND NECK CANCER PATIENTS	IJUP2014 (Porto, Portugal)
2013/11	MIR-125B EXPRESSION IN HPV INFECTION AND CERVICAL CANCER DEVELOPMENT: A POTENTIAL BIOMARKER	EUROGIN 2013 (Florença, Italy)
2013/10	CMV DRUG RESISTANCE GENOTYPING: UTILITY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS (A WORK IN PROGRESS)	IV Congresso Nacional de Virologia (Lisboa, Portugal)
2013/10	DETECTON OF VIRUSES IN SALIVA OF HEAD AND NECK CANCER PATIENTS	IV Congresso Nacional de Virologia (Lisboa, Portugal)
2012/06	POLIMORFISMOS EM GENES DA VIA DA PROSTAGLANDINA E2 (PGE2) COMO MARCADORES DE RISCO PARA O DESENVOLVIMENTO DE CANCRO COLO-RETAL	Semana Digestiva 2012 (Porto, Portugal)
2011	MONITORIZAÇÃO DA INFECÇÃO POR CITOMEGALOVIRUS EM TRANSPLANTADOS DE MEDULA ÓSSEA: ESTUDO RETROSPECTIVO DA EXPERIÊNCIA NO IPO PORTO.	Jornadas de Oncologia Médica (2011) (Portugal)
2006	PREVALÊNCIA DO VÍRUS DE EPSTEIN-BARR (EBV) EM CIRCULAÇÃO EM INDIVÍDUOS COM CARCINOMA GÁSTRICO.	XII Jornadas de Oncologia Médica (Portugal)
2006	POLIMORFISMO -308G>A DO GENE TNF-ALFA COMO MARCADOR DE SUSCEPTIBILIDADE PARA DESENVOLVIMENTO DE CARCINOMA DA NASOFARINGE.	XII Jornadas de Oncologia Médica (Portugal)
2006	POLIMORFISMO -765G>C DA COX-2 PODE REPRESENTAR UM MARCADOR DE RISCO PARA ADENOCARCINOMA GÁSTRICO EM DOENTES COM ATROFIA GÁSTRICA OU METAPLASIA INTESTINAL.	Congresso Nacional de Gastrenterologia (Portugal)
2005	POLIMORFISMO NO GENE P53 E SUSCEPTIBILIDADE ASSOCIADA AO GENÓTIPO PRO/PRO PARA DESENVOLVIMENTO DE CARCINOMA DA NASOFARINGE.	10º Congresso Nacional de Oncologia (Portugal)
2003	QUICK PROTOCOL FOR DNA EXTRACTION IN CERVICAL SWABS USED FOR HUMAN PAPILLOMAVIRUS (HPV) DIAGNOSIS.	1st FEMS European Congress of Microbiologists (Ljubljana, Slovenia)

Supervision

	Thesis Title Role	Degree Subject (Type) Institution / Organization
2016 - Current	HPV and Oropharyngeal Carcinomas Supervisor	Investigacion Aplicada a las Ciencias Sanitarias (PhD) Universidad de León, Spain
2016 - Current	Cytomegalovirus Immune Surveillance in Hematopoietic Stem Cell Transplanted Patients Supervisor	Doutoramento em Patologia e Genética Molecular (PhD) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2018 - 2020/02	HEV in allo-HSCT patients Supervisor	Microbiologia Aplicada (Master) Escola Superior de Biotecnologia (UCP), Portugal
2018 - 2019/12/02	MDM2 in EBV-associated Gastric Cancer Supervisor	Oncologia (Master) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014 - 2018	EBV-assotiated Gastric Cancer: epidemiological and molecular characterization of viral carcinogenesis Supervisor	Investigação Clínica e em Serviços de Saúde (PhD) Universidade do Porto Faculdade de Medicina, Portugal
2014 - 2018	Epstein-Barr Virus and development of PTLD in hematopoietic stem cell transplant recipients: viral activity and host susceptibility Supervisor	Doutoramento em Patologia e Genética Molecular (PhD) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016 - 2017	Polymorphisms in DNA regulation-associated genes and development of Gastric Cancer Supervisor	Medicina e Oncologia Molecular (Master) Universidade do Porto Faculdade de Medicina, Portugal
2015 - 2016	Mechanisms of p53-silencing in Epstein-Barr Virus associated gastric cancer Supervisor	Oncologia (Master) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014 - 2015	Characterization of Cytomegalovirus resistant strains in Hematopoietic Stem cell Transplanted patients Supervisor	Medicina e Oncologia Molecular (Master) Universidade do Porto Faculdade de Medicina, Portugal
2014 - 2015	Epstein-Barr Virus latent gene expression in Nasopharyngeal and Gastric Carcinoma Supervisor	Oncologia (Master) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014 - 2015	Poliomavirus BK viruria and viremia in Hematopoietic Stem Cell Transplantation Supervisor	Oncologia (Master) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014 - 2015	Identification of viral proteins in saliva from patients with head and neck cancers Co-supervisor	Bioquímica Clínica (Master) Universidade de Aveiro, Portugal
2013 - 2014	Characterization of Epstein-Barr Virus associated gastric cancers Supervisor	Microbiologia Aplicada (Master) Escola Superior de Biotecnologia (UCP), Portugal
2013 - 2014	Perfil imunológico de susceptibilidade genética para infeção por EBV em doentes submetidos a aHSCT Supervisor	Oncologia (Master) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2012 - 2013	Infection by EBV and HPV in head and neck cancers Supervisor	Bioquímica Clinica (Master) Universidade de Aveiro Departamento de Biologia, Portugal
2012 - 2013	Role of genetic polymorphisms in PTGS2 and HPGD in colorectal cancer development Supervisor	Biologia Celular e Molecular (Master) Universidade do Porto Faculdade de Ciências, Portugal
2011 - 2012	Prevalence of human herpesvirus infections in cervical samples: contributes for epidemiological approaches Supervisor	Microbiologia Aplicada (Master) Escola Superior de Biotecnologia (UCP), Portugal
2011 - 2012	Genetic markers of Human Papillomavirus (HPV) infection and its clinIcal utility Supervisor	Medicina e Oncologia Molecular (Master) Universidade do Porto Faculdade de Medicina, Portugal
2009 - 2010	Susceptibility to infection by EBV: CD21 polymorphisms and nasopharyngeal cancer Co-supervisor	Cancer Biology and Therapy (Master) University of Central Lancashire School of Pharmacy and Biomedical Sciences, United Kingdom
2009 - 2010	Caracterização do Vírus de Epstein-Barr em doentes com Carcinoma Gástrico Co-supervisor	Oncologia (Master) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2009 - 2010	Molecular epidemiology of HBV infection: genetic polymorphisms on p53 and MDM2 Co-supervisor	Biologia (Master) Universidade do Porto Faculdade de Ciências, Portugal
2007 - 2008	Polimorfismos dos genes TP53, P53BP1 e ATM: Susceptibilidade para cancro do colo do útero Co-supervisor	Medicina e Oncologia Molecular (Master) Universidade do Porto Faculdade de Medicina, Portugal

Event organisation

	Event name Type of event (Role)	Institution / Organization
2016/05/09 - 2016/05/20	1st Advanced Course in Clinical and Molecular Virology (2016/05/09 - 2016/05/20) Other (President of the Organising Committee)	Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2015/09/17 - 2015/09/20	30th International Papillomavirus Conference & Clinical and Public Health Workshops (2015/09/17 - 2015/09/20) Congress (Member of the Organising Committee)	Sociedade Portuguesa de Papilomavirus, Portugal
2012/06/26 - 2012/06/26	Debate: O Papel do Homem na Luta Contra o Cancro (2012/06/26 - 2012/06/26) Conference (President of the Organising Committee)	Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal
2012/02 - 2012/06	UM DIA PELA VIDA em BARCELOS (Relay for life) (2012/02 - 2012/06) Other (President of the Organising Committee)	Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal
2012/02 - 2012/06	RELAY FOR LIFE in BARCELOS (2012/02 - 2012/06) Other (President of the Organising Committee)	Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal
2009/04/24 - 2009/04/24	HPV, Cancer Prevention and Vaccination (2009/04/24 - 2009/04/24) Symposium (Member of the Organising Committee)	Sociedade Portuguesa de Papilomavirus, Portugal
2006 - 2006	1º Ciclo de Conferências sobre Saúde: Os Virus (2006 - 2006)	Mais Juventude - Associação de Jovens de Alvelos, Portugal
2004/09 - 2004/09	I Seminário Mestrado em Oncologia: Que Futuro para a Oncologia? (2004/09 - 2004/09) Symposium (Member of the Organising Committee)	Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Event participation

	Activity description Type of event	Event name Institution / Organization
2020/02/04 - 2020/02/04	Prevenir o Cancro: O Que Precisamos de Saber? Conference	Prevenir o Cancro: O Que Precisamos de Saber? Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal

Jury of academic degree

	Topic Role	Candidate name (Type of degree) Institution / Organization
2020/03/03	Study of oropharyngeal carcinogenesis induced by human papilloma virus type 16 (HPV16) in a murine model (Thesis) Main arguer	Verónica Mestre (Master) Universidade de Trás-os-Montes e Alto Douro, Portugal
2020/03/02	Metabolic networks and metabolism in acute myeloid leukemia Thesis Member	Olga Pereira (PhD) Universidade do Minho, Portugal
2019/09/16	“Drugging p53-impaired tumors: impact of new small molecules targeting p73 and mutant p53”. Thesis Member	SARA MOREIRA (PhD) Universidade do Porto, Portugal
2019/03	Efeito terapêutico do parecoxib: um estudo in vivo em Mus musculus (Thesis) Main arguer	TIAGO TERRAS FERREIRA (Master) Universidade de Trás-os-Montes e Alto Douro Escola de Ciências e Tecnologia, Portugal
2015/01/08	Prevalência da infeção e caraterização molecular do Virus do Papiloma Humano, em alunas dos 17 aos 19 anos da Universidade do Minho, antes da inclusão da vacina no Programa Nacional de Vacinação (Thesis) Main arguer	MARIANA VIERIA MARTINS (Other) Universidade do Minho Escola de Medicina, Portugal
2014/02/11	New approaches for the diagnosis of Human Papillomavirus infection: relevance for clinical practice and cancer prevention (Thesis) Main arguer	ANA CATARINA GRADÍSSIMO DE OLIVEIRA (PhD) Universidade de Lisboa Faculdade de Ciências, Portugal
2011/12/15	Polimorfismo no Gene P21: Estudo da influência na susceptibilidade para o Cancro da Nasofaringe (Thesis) Main arguer	SOFIA MÓNICA SANTOS SOARES (Master) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Association member

	Society Organization name	Role
2009 - Current	Sociedade Portuguesa de Virologia
2009 - Current	European Society for Clinical Microbiology and Infectious Diseases (ESCMID)
2009 - Current	European Society of Clinical Virology (ESCV)
2007 - Current	Sociedade Portuguesa de Papillomavirus

Committee member

	Activity description Role	Institution / Organization
2006 - 2007	Programa de Apoio à Investigação Oncológica no Norte de Portugal Coordinator	Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal

Conference scientific committee

	Conference name	Conference host
2016/05 - 2016/05	1st Advanced Course in Clinical and Molecular Virology
2015 - 2015	30th International PapillomavirusConference & Clinical and Public HealthWorkshops

Course / Discipline taught

	Academic session	Degree Subject (Type)	Institution / Organization
2021/03 - Current	GENERAL PATHOLOGY	Physiotherapy (Licenciatura)	Instituto Superior de Saúde, Portugal
2021/03 - Current	MEDICAL PATHOLOGY	NURSING (Licenciatura)	Instituto Superior de Saúde, Portugal
2020/09 - Current	GENERAL PATHOLOGY	CTeSP Termalismo e Bem-Estar (Curso Técnico Superior Profissional)	Instituto Superior de Saúde, Portugal
2020/09 - Current	ANATOMOPHYSIOLOGY	CTeSP Termalismo e Bem-Estar (Curso Técnico Superior Profissional)	Instituto Superior de Saúde, Portugal
2015 - Current	Investigação em Oncologia	Pós Graduação em Oncologia (Outros)	Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal
2011 - Current	Virologia	Microbiologia (Licenciatura)	Escola Superior de Biotecnologia (UCP), Portugal
2009/09 - Current	Introdução às Tecnicas de Biologia Molecular	(Outros)	Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2011 - 2012	PATOLOGIA MOLECULAR Virus e Cancro	Terapias Moleculares (Mestrado integrado)	Cooperativa de Ensino Superior Politécnico e Universitário, Portugal
2009 - 2009	Introdução à Virologia	(Outros)	Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
2005/06 - 2006	Farmacogenómica	Medicina e Oncologia Molecular (Mestrado integrado)	Universidade do Porto Faculdade de Medicina, Portugal
2005/06 - 2006	Epidemiologia Molecular	(Outros)	Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Evaluation committee

	Activity description Role	Institution / Organization	Funding entity
2020 - 2020	ENJIO – 2º Encontro Nacional de Jovens Investigadores em Oncologia Evaluator	Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal	Liga Portuguesa Contra o Cancro Núcleo Regional do Norte
2020 - 2020	FAF - Grants 2020 - Fundamental research Evaluator	Belgian Foundation Against Cancer, Belgium	Belgian Foundation Against Cancer

Interview (newspaper / magazine)

	Activity description	Newspaper / Forum
2017/07/27	Entrevista na sequência de prémio "Abbot Diagnostic Award 2017"	Publico/P3
2017/07/10	Publicação na sequência do Prémio "Abbot Diagnostic Award 2017"
2017/03/02	HPV e Cancro do Colo do Útero: Prevenir!”	ULSNE CONSIGO, Mensageiro de Bragança

Interview (tv / radio show)

	Program	Topic
2021/01/30 - Current	BOM DIA PORTUGAL, RTP	HPV e Cancro do Colo do Útero
2021/01/27 - Current	JORNAL DA UMA, TVI	HPV E RASTREIO DO CANCRO DO COLO DO ÚTERO
2020/03/20 - Current	NOS, JORNAL ONLINE DA UMINHO	O SARS-CoV-2 é um alerta para o futuro da humanidade
2020/03/13 - Current	ACADEMIA, RÁDIO UNIVERSITÁRIA DO MINHO	Tudo o que precisa saber sobre a Covid 19
2019/09/19 - Current	SOCIEDADE, RTP MADEIRA	RASTREIO DO CANCRO DO COLO DO ÚTERO NO SÉC. XXI
2019/02/28 - Current	MARATONA DA SAUDE, ANTENA 1	HPV e Cancro do Colo do Útero
2019/01/28 - Current	Praça da Alegria	HPV e Cancro do Colo do Útero
2018/02/05 - Current	NAMINHATERRA.TV	CICLO DE CONFERÊNCIAS DEDICADAS AO CÓDIGO EUROPEU CONTRA O CANCRO
2018/01/16 - Current	CONSULTÓRIO, PORTO CANAL	HPV e Cancro do Colo do Útero

Other jury / evaluation

	Activity description	Institution / Organization
2019 - 2019	GRADUATE WOMEN IN SCIENCE scholarships 2019	Graduate Women in Science, United States
2019 - 2019	Bolsa de Investigação em Oncologia LPCC-NRN / UMinho 2019	Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal

Distinctions

Award

2018	Profissional do Ano Rotary Club de Barcelos, Portugal
2017	ABBOT AWARD FOR CLINICAL VIROLOGY DIAGNOSIS European Society for Clinical Virology, United Kingdom
2016	PBJ SANTANDER PRIZE FOR SCIENTIFIC EXCELLENCE Porto Biomedical Journal, Portugal
1999	Melhor Aluno a Entrar no Curso de Microbiologia no Ano Lectivo 1999/2000 Banco Espirito Santo / Escola Superior de Biotecnologia - Universidade Católica Portuguesa, Portugal

Other distinction

2023	IDEX Scholarship for the European Master's in Molecular Pathology Université Côte d'Azur Faculté de Médecine, France
2018	GRANT for the attendance of “Hepatitis Workshop” European Society for Clinical Virology, United Kingdom
2014	3rd place in BEST ORAL PRESENTATION at 13º Congresso Nacional de Oncologia, Porto 2014.
2014	3rd place in BEST POSTER at 13º Congresso Nacional de Oncologia, Porto 2014
2014	GRANT for attendance of “Educational Programme on Transplant Infectious Diseases - Postgraduate Education Course” European Society of Clinical Microbiology and Infectious Diseases, Switzerland
2012	POSTER OF EXCELLENCE at 20th United European Gastroenterology Week (UEGW12), 20-24 Out 2012, Amsterdão HOLANDA
2010	Apoio Monetário da Fundação Professor Ernesto Morais (2010) - 2º LUGAR
2010	Apoio Monetário da Fundação Professor Ernesto Morais (2º lugar)
2008	PhD Scholarship (SFRH/BD/40718/2007) Fundação para a Ciência e a Tecnologia, Portugal
2007	Best Poster for Basic Research Jornadas de Oncologia Médica do IPO Porto, Portugal
2006	Melhor Comunicação Livre em "Investigação Básica" Jornadas de Oncologia Médica do IPO-Porto, Portugal
2006	Melhor Poster em "Investigação Básica" Jornadas de Oncologia Médica do IPO Porto, Portugal